Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Beatrice Kallungal"'
Autor:
Rajesh T. Gandhi, Lu Zheng, Ronald J. Bosch, Ellen S. Chan, David M. Margolis, Sarah Read, Beatrice Kallungal, Sarah Palmer, Kathy Medvik, Michael M. Lederman, Nadia Alatrakchi, Jeffrey M. Jacobson, Ann Wiegand, Mary Kearney, John M. Coffin, John W. Mellors, Joseph J. Eron
Publikováno v:
PLoS Medicine, Vol 8, Iss 8 (2011)
Externí odkaz:
https://doaj.org/article/f927af108d2c49179068595edb21d142
Autor:
Rajesh T Gandhi, Lu Zheng, Ronald J Bosch, Ellen S Chan, David M Margolis, Sarah Read, Beatrice Kallungal, Sarah Palmer, Kathy Medvik, Michael M Lederman, Nadia Alatrakchi, Jeffrey M Jacobson, Ann Wiegand, Mary Kearney, John M Coffin, John W Mellors, Joseph J Eron, AIDS Clinical Trials Group A5244 team
Publikováno v:
PLoS Medicine, Vol 7, Iss 8, p e1000321 (2010)
Most HIV-1-infected patients on effective antiretroviral therapy (ART) with plasma HIV-1 RNA levels below the detection limits of commercial assays have residual viremia measurable by more sensitive methods. We assessed whether adding raltegravir low
Externí odkaz:
https://doaj.org/article/ea37066179f74b4490ef6ff4cce51619
Autor:
Yoninah S Cramer, Victoria A. Johnson, Michael S. Saag, Beatrice Kallungal, Edward P. Acosta, Eoin Coakley, Stephen Becker, Gary Calandra, Karin L. Klingman, Susan L. Rosenkranz
Publikováno v:
AIDS Res Hum Retroviruses
AMD11070 binds to the chemokine receptor CXCR4, with anti-HIV-1 activity in vitro and in vivo. We conducted a phase IB/IIA proof-of-concept dose-escalating, open-label study to determine safety and antiviral activity of AMD11070 administered over 10
Autor:
Ying Jun Cao, Jeong Gun Park, Nimalie D. Stone, Ron MacFarland, Charles Flexner, Beatrice Kallungal, Craig W. Hendrix, Ilene Wiggins, Sally Snyder, Camlin Tierney, Jeanne Conley, Stephen Becker, Christina M. Lalama, Karin L. Klingman, Gary Calandra, Shelia B. Dunaway
Publikováno v:
Antimicrobial Agents and Chemotherapy. 51:2351-2358
AMD070 is an oral CXCR4 antagonist with in vitro activity against X4-tropic human immunodeficiency virus type 1. Thirty fasting healthy male volunteers received oral doses of AMD070 ranging from a single 50-mg dose to seven 400-mg doses given every 1
Autor:
Michael Norton, David Katzenstein, Khuanchai Supparatpinyo, Sharlaa Badal-Faesen, Evgenia Aga, Heather J. Ribaudo, Karin L. Klingman, Wendy S. Stevens, Beatrice Kallungal, Nagalingeswaran Kumarasamy, John A. Crump, Mina C. Hosseinipour, John Bartlett, Carole L. Wallis
Publikováno v:
AIDS (London, England). 26(11)
OBJECTIVE To evaluate virologic response rates of lopinavir/ritonavir (LPV/r) monotherapy as second-line antiretroviral treatment (ART) among adults in resource-limited settings (RLSs). DESIGN An open-label pilot study of LPV/r monotherapy in partici
Autor:
Eric S. Daar, Elizabeth Connick, Beatrice Kallungal, Karen T. Tashima, Bernard J.C. Macatangay, Susan A. Fiscus, Rob Camp, Christine Hogan, C. Bradley Hare, Victor DeGruttola, Carlos del Rio, Susan J. Little, Martin Markowitz, Xin Sun, Tia Morton
Publikováno v:
The Journal of infectious diseases. 205(1)
The role of antiretroviral therapy (ART) during acute and early human immunodeficiency virus type 1 (HIV-1) infection has been an area of investigation for several years; however, the benefits of such treatment remain unproved, and best practice for
Autor:
Rajesh T, Gandhi, Robert W, Coombs, Ellen S, Chan, Ronald J, Bosch, Lu, Zheng, David M, Margolis, Sarah, Read, Beatrice, Kallungal, Ming, Chang, Erin A, Goecker, Ann, Wiegand, Mary, Kearney, Jeffrey M, Jacobson, Richard, D'Aquila, Michael M, Lederman, John W, Mellors, Joseph J, Eron, Martha, Silberman
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 59(3)
Controversy continues regarding the extent of ongoing viral replication in HIV-1-infected patients on effective antiretroviral therapy (ART). Adding an additional potent agent, such as raltegravir, to effective ART in patients with low-level residual